Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > FDA approval

<< Previous

Bullboard Posts

Next >>

Comment by QContinuum1on Apr 29, 2024 8:17am

101 Views

Post# 36012248

RE:FDA approval

Solid1 wrote:
Let's not kid ourselves, the big hit is FDA approval

From then on, no more PR is needed - it will spread quickly.

But the wait is already driving you a bit crazy :-D

Don't know if ANDA approval is coming any time soon given the recent-ish judge ruling. I think nearer term is Brazil, their partner and what all that means. Between Germany and Brazil, those two jurisdictions alone ought drive positivity and not by a small measure.

What the ends up doing to the SP is anyone's guess mind you. But certainly, if LABS gets a ruling/FDA gift, you'd think we'd get a 10 banger from here.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages